UK markets closed
NIKKEI 225
38,236.07 -38.03 (-0.10%) HANG SENG
18,493.66 +17.74 (+0.10%) CRUDE OIL
78.42 +0.31 (+0.40%) GOLD FUTURES
2,320.30 +11.70 (+0.51%) DOW
38,675.68 +449.98 (+1.18%) Bitcoin GBP
50,812.73 +407.40 (+0.81%)
Eastwood Bio-Medical Canada Inc. (EBM.V)
TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
At close: 10:31AM EDT
Currency in CAD
Valuation measures4
| Market cap (intra-day) | 60.62M |
| Enterprise value | 60.67M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 82.28 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 82.34 |
| Enterprise value/EBITDA | -148.48 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.56 |
| 52-week change 3 | 7.32% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 1.1000 |
| 52-week low 3 | 0.4000 |
| 50-day moving average 3 | 0.7124 |
| 200-day moving average 3 | 0.7128 |
Share statistics
| Avg vol (3-month) 3 | 731 |
| Avg vol (10-day) 3 | 300 |
| Shares outstanding 5 | 68.89M |
| Implied shares outstanding 6 | 68.89M |
| Float 8 | 20.95M |
| % held by insiders 1 | 69.55% |
| % held by institutions 1 | 0.00% |
| Shares short (28 Mar 2024) 4 | 56 |
| Short ratio (28 Mar 2024) 4 | 0.05 |
| Short % of float (28 Mar 2024) 4 | N/A |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.00% |
| Shares short (prior month 15 Feb 2024) 4 | 3k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Oct 2023 |
| Most-recent quarter (mrq) | 31 Jan 2024 |
Profitability
| Profit margin | -72.15% |
| Operating margin (ttm) | -31.25% |
Management effectiveness
| Return on assets (ttm) | -64.96% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 736.75k |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | -39.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -436.37k |
| Net income avi to common (ttm) | -531.6k |
| Diluted EPS (ttm) | -0.0100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 6.02k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 51.89k |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.07 |
| Book value per share (mrq) | -0.01 |
Cash flow statement
| Operating cash flow (ttm) | -7.53k |
| Levered free cash flow (ttm) | 180.07k |
© 2024 Yahoo. All rights reserved.